KVUE - Kenvue Inc Stock Analysis

Kenvue Inc (KVUE) is a publicly traded company listed on the NYSE. It operates in the Household & Personal Products industry, part of the broader Consumer Defensive sector. The company has a market capitalization of 32.11B, generates annual revenue of 15.01B, and reports net income of 1.43B. As of the latest data, the stock is trading at 16.76 USD.

From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The stock provides a high dividend yield (4.91%), which could indicate strong income potential — or possible risk. This stock tends to be less volatile than the overall market, often preferred by conservative investors.

Analyst recommendation stands at Hold (3.43), indicating current market sentiment. Institutional ownership is reported at 98.35%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -27.63%, trading within a 52-week range of 14.02 - 25.17.

KVUE - Kenvue Inc

16.76
Analyst Consensus
Hold 3.43
KVUE – Analyst Rating Summary
Analyst Pie Chart
  • Strong Buy: 3
  • Buy: 4
  • Hold: 13
  • Sell: 1
  • Strong Sell: 0
  • Total Analysts:  21

Last update: 2025-12-09 04:34:10
Index: S&P 500 P/E: 22.53 EPS (ttm): 0.74 Insider Own: 0.06% Shs Outstand: 1.92B Perf Week: -2.67%
Market Cap: 32.11B Forward P/E: 15.13 EPS next Y: 1.11 Insider Trans: 0.00% Shs Float: 1.91B Perf Month: 1.82%
Income(ttm): 1.43B PEG: 19.76 EPS next Q: 0.23 Inst Own: 98.35% Short Float: 1.41% Perf Quarter: -11.18%
Revenue(ttm): 15.01B P/S: 2.14 EPS this Y: -9.38% Inst Trans: -2.76% Short Ratio: 0.66 Perf Half Y: -21.31%
Book/sh: 5.55 P/B: 3.02 EPS next Y: 7.21% ROA: 5.29% Short Interest: 27.02M Perf Year: -27.63%
Cash/sh: 0.59 P/C: 28.19 EPS next 5Y: 1.14% ROE: 13.47% 52W Range: 14.02 - 25.17 Perf YTD: -21.50%
Dividend Est.: 0.82 (4.91%) P/FCF: 19.66 EPS past 3/5Y: -20.60% -6.66% ROIC: 8.05% 52W High: 25.17 -33.41% Beta: 0.56
Dividend TTM: 0.83 (4.93%) Quick Ratio: 0.69 Sales past 3/5Y: 0.91% 1.54% Gross Margin: 58.21% 52W Low: 14.02 19.54% Perf 5Y: -
Dividend Ex-Date: Nov 12, 2025 Current Ratio: 0.98 EPS Y/Y TTM: 34.54% Oper. Margin: 18.20% RSI (14): 52.62 Volatility: 1.62% 2.48%
Employees: 22000 Debt/Eq: 0.86 Sales Y/Y TTM: -2.94% Profit Margin: 9.55% Recom: 2.65 Target Price: 19.00
Option/Short: Yes / Yes LT Debt/Eq: 0.67 EPS Q/Q: 3.97% Payout: 150.50% Rel Volume: 0.63 Prev Close: 16.93
Sales Surprise: -1.46% EPS Surprise: 7.61% Sales Q/Q: -3.51% Earnings: Nov 03 BMO Avg Volume: 40.80M Price: 16.76
SMA20: 0.06% SMA50: 4.25% SMA200: -18.16% Undervalued: 13.37%
Volume: 25,700,442 Change: -1.00%
Graham's revised valuation formula
Discounted cash flow (DCF) model
Margin of safety

About Kenvue Inc

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson's, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.

Copyright © 2024 - 2025 www.stocks-expert.com All Rights Reserved.